{
  "paper_metadata": {
    "pmid": "35999650",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data for affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Val142Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 35,
        "demographics": "Median age 78 years, 82% \u226570 years, 16% female, 99% Caucasian",
        "phenotype": "Hereditary transthyretin amyloidosis (ATTRv)"
      },
      "penetrance_data": {
        "total_carriers_observed": 35,
        "affected_count": 13,
        "unaffected_count": 22,
        "uncertain_count": null,
        "penetrance_percentage": 37.14,
        "age_dependent_penetrance": [
          {
            "age_range": "\u226570 years",
            "penetrance_percentage": 5.3,
            "carriers_in_range": 13,
            "affected_in_range": 1
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 93,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Transthyretin amyloid cardiomyopathy",
          "evidence_sentence": "The eldest ATTRv patient diagnosed was a 93-year-old Caucasian female with the Val142Ile variant."
        }
      ],
      "functional_data": {
        "summary": "The Val142Ile variant is associated with hereditary transthyretin amyloidosis.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families as indicated by genetic testing in relatives.",
      "population_frequency": null,
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study highlights the importance of genetic testing in elderly patients with ATTR-CM.",
      "key_quotes": [
        "Diagnosis of ATTRv in elderly ATTR\u2010CM patients allowed initiation of transthyretin\u2010specific drug treatment in 5 individuals.",
        "Identification of 9 ATTRv asymptomatic carriers."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 35,
        "demographics": "Median age 78 years, 82% \u226570 years, 16% female, 99% Caucasian",
        "phenotype": "Hereditary transthyretin amyloidosis (ATTRv)"
      },
      "penetrance_data": {
        "total_carriers_observed": 35,
        "affected_count": 13,
        "unaffected_count": 22,
        "uncertain_count": null,
        "penetrance_percentage": 37.14,
        "age_dependent_penetrance": [
          {
            "age_range": "\u226570 years",
            "penetrance_percentage": 5.3,
            "carriers_in_range": 13,
            "affected_in_range": 1
          }
        ]
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The Val50Met variant is associated with hereditary transthyretin amyloidosis.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families as indicated by genetic testing in relatives.",
      "population_frequency": null,
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study highlights the importance of genetic testing in elderly patients with ATTR-CM.",
      "key_quotes": []
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Extracted data is based on the information provided in the main text."
  }
}